Cyma Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.50 Cr
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.48 Cr
- Satisfied Charges ₹ 7.72 Cr
- Revenue Growth -20.29%
- Profit Growth -35.00%
- Ebitda -21.80%
- Net Worth 8.32%
- Total Assets 2.63%
About Cyma Life Sciences
Cyma Life Sciences Private Limited (CLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 July 2007 and has a history of 17 years and six months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹9.48 Cr. The company has closed loans amounting to ₹7.72 Cr, as per Ministry of Corporate Affairs (MCA) records.
Narendra Balusu, Lakshmana Balusu, Sudha Balusu, and One other member serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232TG2007PTC054924
- Company No.
054924
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2007
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Cyma Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Balusu  | Director | 11-Jun-2008 | Current |
| Lakshmana Balusu | Director | 27-May-2008 | Current |
| Sudha Balusu | Director | 01-Apr-2014 | Current |
| Sai Balusu | Director | 13-Oct-2021 | Current |
Financial Performance of Cyma Life Sciences.
Cyma Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.29% decrease. The company also saw a substantial fall in profitability, with a 35% decrease in profit. The company's net worth moved up by a moderate rise of 8.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cyma Life Sciences?
In 2023, Cyma Life Sciences had a promoter holding of 64.00% and a public holding of 36.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Krs Pharmaceuticals Private LimitedNarendra Balusu, Lakshmana Balusu and 1 more are mutual person
Ocean Pharmacoat Private LimitedNarendra Balusu, Lakshmana Balusu and 1 more are mutual person
Nanda Nandana Estates & Farms Private LimitedLakshmana Balusu and Sudha Balusu are mutual person
- Blue Ribbon Technologies Private Limited
Sai Balusu is a mutual person
Charges (Loans)
₹9.48 Cr
₹7.72 Cr
Charges Breakdown by Lending Institutions
- Others : 9.48 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2024 | Others | ₹4.50 Cr | Open |
| 29 Oct 2018 | Others | ₹4.98 Cr | Open |
| 20 Oct 2010 | State Bank Of India | ₹2.74 Cr | Satisfied |
| 18 Aug 2009 | State Bank Of India | ₹4.98 Cr | Satisfied |
How Many Employees Work at Cyma Life Sciences?
Cyma Life Sciences has a workforce of 8 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cyma Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyma Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
